Laboratorios Farmaceuticos Rovi, S.A. Share Price
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
BME
16:35:16 02/09/2026 BST
|
After hours 20:59:56 | |||
| 59.90 EUR | -0.17% |
|
59.92 | +0.04% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.06B 3.55B 2.89B 2.63B 4.91B 335B 4.95B 34.17B 13.26B 172B 13.33B 13.04B 563B | P/E 2026 * |
21.5x | P/E 2027 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.05B 3.53B 2.87B 2.62B 4.89B 334B 4.93B 33.98B 13.19B 171B 13.26B 12.97B 560B | EV / Sales 2026 * |
3.95x | EV / Sales 2027 * | 3.35x |
| Free-Float |
31.63% | Yield 2026 * |
1.61% | Yield 2027 * | 1.95% |
Last Transcript : Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -0.13% | ||
| 1 week | -1.48% | ||
| Current month | -1.16% | ||
| 1 month | +2.31% | ||
| 3 months | +3.54% | ||
| 6 months | -27.92% | ||
| Current year | -5.67% |
| 1 week | 59.35 |  | 62.2 |
| 1 month | 57.3 | | 62.2 |
| Current year | 53.1 | | 86.7 |
| 1 year | 53.1 | | 86.7 |
| 3 years | 45.52 | | 94.8 |
| 5 years | 35.2 | | 94.8 |
| 10 years | 10.8 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 26/07/2007 | |
| Director of Finance/CFO | - | 31/12/2000 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 16/07/2021 | |
| Director/Board Member | - | 26/07/2007 | |
| Director/Board Member | - | 26/07/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/06/23 | Buy | Director | 1,000 | 0.0019% | ||
| 13/04/22 | Norbel Inversiones SL
| Sell | Company | 560,690 | 1.0000% | |
| 15/03/22 | Norbel Inversiones SL
| Sell | Company | 2,803,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.17% | -1.48% | +2.92% | +14.20% | 3.56B | |
| +0.34% | -2.26% | +58.12% | +108.26% | 1,034B | |
| +1.59% | +2.06% | +54.76% | +71.50% | 654B | |
| +0.65% | -0.80% | +23.06% | +78.50% | 459B | |
| +0.49% | -5.19% | +33.28% | +35.53% | 343B | |
| +0.27% | +3.26% | +29.76% | +47.50% | 307B | |
| +0.12% | -2.11% | +0.60% | +12.03% | 251B | |
| +1.08% | +0.40% | +54.08% | +74.05% | 237B | |
| +2.64% | -1.08% | -15.85% | -53.97% | 202B | |
| -0.19% | +1.21% | +32.98% | +99.41% | 186B | |
| Average | +0.66% | -2.68% | +27.37% | +48.70% | 367.51B | |
| Weighted average by Cap. | +0.70% | -3.31% | +38.89% | +67.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 772M 894M 727M 662M 1.24B 84.5B 1.25B 8.61B 3.34B 43.2B 3.36B 3.29B 142B | 891M 1.03B 839M 765M 1.43B 97.54B 1.44B 9.93B 3.86B 49.87B 3.88B 3.79B 164B |
| Net income | 129M 149M 121M 110M 206M 14.08B 208M 1.43B 556M 7.2B 559M 547M 23.64B | 174M 202M 164M 149M 279M 19.04B 281M 1.94B 753M 9.73B 757M 740M 31.98B |
| Net Debt | -16.21M -18.79M -15.27M -13.92M -26.01M -1.78B -26.21M -181M -70.18M -908M -70.57M -69.03M -2.98B | -81.51M -94.48M -76.78M -69.96M -131M -8.93B -132M -909M -353M -4.56B -355M -347M -14.99B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/09/26 | €59.90 | -0.17% | 73,130 |
| 01/09/26 | €60.00 | -0.99% | 77,364 |
| 31/08/26 | €60.60 | -0.41% | 127,383 |
| 28/08/26 | €60.85 | -1.06% | 106,765 |
| 27/08/26 | €61.50 | +1.15% | 154,874 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
